Avidian Wealth Solutions, LLC Veracyte, Inc. Transaction History

Avidian Wealth Solutions, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	BUY	$16.58 - $27.9 $16,580 - $27,900	1,000 Added 9.09%	12,000 $199,000
Q2 2022 Jul 29, 2022	BUY	$15.45 - $29.52 $15,450 - $29,520	1,000 Added 10.0%	11,000 $219,000
Q1 2022 May 10, 2022	BUY	$21.94 - $42.51 $109,700 - $212,550	5,000 Added 100.0%	10,000 $276,000
Q3 2021 Nov 10, 2021	BUY	$35.62 - $52.97 $178,100 - $264,850	5,000 New	5,000 $232,000

316

81.8M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.23B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Avidian Wealth Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Avidian Wealth Solutions, LLC with notifications on news.